These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26422464)

  • 1. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
    Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
    Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.
    Mukherjee J; Majji D; Kaur J; Constantinescu CC; Narayanan TK; Shi B; Nour MT; Pan ML
    Synapse; 2017 Mar; 71(3):. PubMed ID: 27864853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.
    Kaur J; Khararjian A; Coleman RA; Constantinescu CC; Pan ML; Mukherjee J
    Nucl Med Biol; 2014; 41(10):841-7. PubMed ID: 25199843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.
    Choi JK; Mandeville JB; Chen YI; Grundt P; Sarkar SK; Newman AH; Jenkins BG
    Psychopharmacology (Berl); 2010 Sep; 212(1):59-72. PubMed ID: 20628733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.
    Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N
    Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.
    McNamara RK; Levant B; Taylor B; Ahlbrand R; Liu Y; Sullivan JR; Stanford K; Richtand NM
    Neuroscience; 2006 Nov; 143(1):141-53. PubMed ID: 16938406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dopamine D3 receptors in thermoregulation: a reappraisal.
    Perachon S; Betancur C; Pilon C; Rostène W; Schwartz JC; Sokoloff P
    Neuroreport; 2000 Jan; 11(1):221-5. PubMed ID: 10683862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates.
    Shi B; Narayanan TK; Christian BT; Chattopadhyay S; Mukherjee J
    Nucl Med Biol; 2004 Apr; 31(3):303-11. PubMed ID: 15028242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta.
    Zingales V; Torrisi SA; Leggio GM; Bucolo C; Drago F; Salomone S
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.
    Wang J; Jia Y; Li G; Wang B; Zhou T; Zhu L; Chen T; Chen Y
    Int J Neuropsychopharmacol; 2018 May; 21(5):448-460. PubMed ID: 29390063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
    Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
    J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
    Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
    Wallace DR; Booze RM
    J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.
    Mason CW; Hassan HE; Kim KP; Cao J; Eddington ND; Newman AH; Voulalas PJ
    J Pharmacol Exp Ther; 2010 Jun; 333(3):854-64. PubMed ID: 20228156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.